Fatemeh Sanjabi
Overview
Explore the profile of Fatemeh Sanjabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fatemi N, Mirbahari S, Tierling S, Sanjabi F, Shahrivari S, AmeliMojarad M, et al.
Dig Dis Sci
. 2025 Jan;
PMID: 39869166
Colorectal cancer (CRC) is ranked as the second leading cause of cancer-related deaths globally, necessitating urgent advancements in therapeutic approaches. The emergence of groundbreaking therapies, including chimeric antigen receptor-T (CAR-T)...
2.
Rejali L, Seifollahi Asl R, Sanjabi F, Fatemi N, Aghdaei H, Saeedi Niasar M, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345083
Colorectal cancer (CRC) is the second cause of cancer-related deaths in both sexes globally and presents different clinical outcomes that are described by a range of genomic and epigenomic alterations....
3.
Plasma miR-183-5p in colorectal cancer patients as potential predictive lymph node metastasis marker
Sanjabi F, Nekouian R, Akbari A, Mirzaei R, Fattahi A
J Cancer Res Ther
. 2022 Sep;
18(4):921-926.
PMID: 36149141
Background: Lymph node metastasis (LNM) is a point that often, treatment is not effective in colorectal cancer (CRC). Clinical and pathologic markers of prognosis help clinicians in selecting patients for...
4.
Nazemalhosseini-Mojarad E, Sanjabi F, Babini H
Biomark Med
. 2020 Apr;
14(6):417-420.
PMID: 32250155
No abstract available.